Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.

Pan X, Arumugam T, Yamamoto T, Levin PA, Ramachandran V, Ji B, Lopez-Berestein G, Vivas-Mejia PE, Sood AK, McConkey DJ, Logsdon CD. Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells. Clin Cancer Res. 2008 Dec 15; 14(24):8143-51.

View in: PubMed

subject areas

Animals
Antimetabolites, Antineoplastic
Apoptosis
Cell Line, Tumor
Deoxycytidine
Drug Resistance, Neoplasm
Gene Silencing
Humans
Male
Mice
Pancreatic Neoplasms
RNA, Small Interfering
Transcription Factor RelA

authors with profiles

Pablo Vivas

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support